All Activity

This article highlights the impactful role of women in the cannabis industry through social media. They're building communities and dismantling stigmas. It's inspiring to see this collaboration. It's almost like watching players level up skills strategically, similar to the precision needed in Ragdoll Archers . The legal cannabis world is gaining strength thanks to these dedicated women.

I have read a few of the articles on your website now, and I really like your style of blogging. I added it to my favorites blog site list and will be checking back soon. Please check out my site as well and let me know what you think. apollo tv group

One of the biggest strengths of the Dinosaur Game is its accessibility. It requires no installation, no account, and no learning curve. Anyone with Google Chrome can play it instantly, regardless of age or gaming experience.

What truly makes Geometry Dash unique is its deep connection between gameplay and music. Every jump, fall, and movement is synchronized with energetic electronic tracks.

By removing direct defensive control, Retro Bowl emphasizes strategic decisions and offensive execution rather than overwhelming the player with complex mechanics.

“Merely hitting pause does not protect public health; thoughtful regulation does.” By Sasha Kalcheff-Korn, Realm of Caring While some policymakers are proposing to delay impending hemp restrictions by extending the 2018 Farm Bill, this is just a band-aid and might ultimately create a significant missed opportunity. An extension may temporarily allow farmers to plant this season, but it does nothing to solve the underlying problem. Kicking the can down the road only prolongs uncertainty for farmers, patients and families, plus it guarantees we will be having the same crisis conversation again next year. We create an industry that can’t plan for the future. The right solution is not just delay; it is clarity. Congress has a narrow window right now to fix the language, correct the THC threshold and clearly distinguish intoxicating products from non-intoxicating, therapeutic CBD—and it should take that opportunity while there is momentum and support to do so. Farmers do not need temporary relief; they need regulatory certainty that allows them to operate responsibly and sustainably. And most importantly, the patients and families who rely on this medicine need therapeutical tools they can depend on. Claims that we need “more research” to determine intoxicating levels of THC in CBD products ignore the substantial body of evidence that already exists. Scientific literature, clinical experience and real-world data consistently demonstrate that non-intoxicating CBD products can contain trace amounts of THC well below any level that produces intoxication. This is not theoretical, but it is observable, measurable and already understood. No organization has engaged more deeply or consistently with the community using cannabinoids than Realm of Caring. Through tens of thousands of direct, recorded interactions with patients, caregivers, clinicians and families across the country, we can confidently articulate what constitutes a non-intoxicating level of THC in commercially available CBD products that have been used responsibly for more than a decade. From our perspective, if lawmakers have the opportunity to pass a reasonable, evidence-based solution, particularly with encouragement from a supportive administration, they should take that shot. This challenge can be viewed as a gift for the industry to come together, end the hemp ambiguity and protect workers and patients. But merely hitting pause does not protect public health; thoughtful regulation does. Sasha Kalcheff-Korn is the executive director of Realm of Caring, a Colorado-based nonprofit that advocates for and connects people to cannabinoid therapy. The post Hemp Farmers And Patients Who Rely On CBD Need More Than Just A Delay In The Looming Federal Ban (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“It is largely up to individuals and dispensaries to ensure they are in compliance with the portion of this rule related to purchases.” By Rebecca Rivas, Missouri Independent Missouri cannabis regulators have changed their guidance on whether or not medical marijuana patients can purchase from licensed dispensaries as a regular consumer, following complaints over the last year that the state’s policy was an unconstitutional restriction. But the update ended up causing more confusion about what patients can or can’t do, cannabis advocates say. In the FAQ section of Missouri Department of Health and Senior Services’ website, it lists the question: As a qualifying patient over the age of 21, can I choose to purchase marijuana as a patient and also purchase marijuana as a consumer? Previously, the answer was a straight “no.” “…patient ID card holders are not allowed to purchase as a consumer in a licensed dispensary,” the department, which is Missouri’s cannabis regulatory agency, stated. The rule, regulators said, was meant to ensure that patients and consumers stay within their allowed possession limits. But on December 8, the department changed the answer to say they don’t exactly know. It now says: “State law does not explicitly address the question of whether an individual may choose to purchase marijuana as a consumer once they have been approved as a patient and assigned a purchase and possession limit according to that status.” The Independent asked DHSS if medical patients need to show their patient ID card every time they buy marijuana from a dispensary—a question the cannabis advocacy group Missouri NORML has urged the department to clarify. Lisa Cox, spokeswoman for the department, said the law is “not clear” about it, “so DHSS is not instructing patients that they must do so,” in an email to The Independent. Dan Viets, an attorney and board member for Missouri NORML, said he’s pleased the department has changed its position on that question—but less so on another issue. Viets initially interpreted the department’s update to mean that the state now agreed with NORML that medical patients may purchase the same amount of cannabis as other adult consumers. In general, medical patients are limited to a 6-ounce allotment of dried, unprocessed marijuana every 30 days. Recreational consumers are allowed to purchase up to 3 ounces every day—but they can’t possess more than 3 ounces at any one time. Cox said it is not the department’s position that “patients and consumers have the same purchase limits. These limits are different in law, and patient limits are often specific to each individual.” She said “the law is clear” that individuals may not exceed purchase limitations by combining patient and consumer purchases. For recreational consumers, the state is prohibited by law from tracking their purchases without their permission. However by law, dispensaries are required to track how much medical marijuana patients buy so they don’t exceed their limit. And dispensaries are required to report to the department if they observe an individual exceeding their purchase or possession limits, which can lead to fines or criminal charges, the department’s website states. Cox said penalties for medical patients are uncommon, and the department has never had to revoke a patient card over possession limits. While there are some extra steps involved, Viets said there are good reasons for people to maintain their patient status. “Not only because you pay less sales tax,” Viets said, “but I think more importantly, because you enjoy the constitutional protection against employment discrimination.” Andrew Mullins, executive director of the Missouri Marijuana Trade Association, sent a letter in April to leaders of the Division of Cannabis Regulation claiming the previous FAQ wording was unconstitutional. “We believe that DCR’s interpretation that a Missourian must either be an adult-use consumer or a medical patient is neither good public policy nor a constitutionally sound interpretation,” he wrote. After the FAQ was changed online, MoCann Trade celebrated the revision. “We are thankful that despite some initial confusion, it now appears that DCR agrees that medical marijuana patients can also exercise their purchasing rights as an adult use customer, so long as they abide by the possession limit,” Mullins told The Independent. He said it’s “especially significant” because Missouri has been increasing its patient count, reaching a two-year high in medical marijuana patient applications last month. “This pro-patient policy clarification,” he said, “now complies with the Missouri Constitution and addresses the concerns we previously articulated on behalf of our medical cannabis customers.” Cox said the department is prohibited from tracking consumer purchases, “so it is largely up to individuals and dispensaries to ensure they are in compliance with the portion of this rule related to purchases.” If there is a need to verify an individual’s possession limits, such as with law enforcement, “it is important that patients know the possession limits applicable to them.” The department, she added, will provide as much guidance as it can to patients and consumers on what is allowed so that they remain within their legal possession limits. This story was first published by Missouri Independent. The post Missouri Regulators Move To Clarify Medical Marijuana Patients’ Purchasing Limits appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The Indiana House of Representatives defeated an amendment aimed at allowing farmers to begin growing marijuana. The amendment, from Rep. Kyle Miller (D), would have directed the state chemist and seed commissioner to issue special use permits to between three and 10 farmers for the cultivation of marijuana seed, with geographic distribution requirements. While Miller framed the proposal as a way to prepare the state for federal marijuana rescheduling under a recent order from President Donald Trump, it was defeated in a voice vote on Thursday. “While this part of the chapter is open, we should get prepared for what Donald Trump, through his executive order, has asked—to reschedule marijuana from a Schedule I to a Schedule III,” the lawmaker said. “The longer we stick our heads in the sand, we’re hurting our farmers, we’re hurting our constituents. We need to move forward on this issue.” Rep. Mike Aylesworth (R), the sponsor of the bill about state seed law, that Miller was seeking to amend, spoke against the proposed change. “The Indiana criminal code prohibits the possession of marijuana seeds that are capable of germination. This amendment seeks to allow the state seed commissioner to offer permits to farmers for an action that is currently illegal in Indiana,” he said, according to The Times of Northwest Indiana. “The amendment does not alter the criminal code and thus creates a statutory conflict.” A poll released this month shows that nearly three in five Indiana residents back legalizing cannabis for medical and recreational use. It found that 59 percent of residents are in favor of legalizing cannabis for both medical and recreational purposes. An additional 25 percent back only allowing patients to access medical marijuana, raising the total support for that reform to 84 percent. The survey was released just days after Indiana Rep. Mitch Gore (D) filed legislation that would effectively legalize the possession and cultivation of limited amounts of marijuana. It’s one of several reform options on the table so far in the legislature for this year’s session. Cannabis reform advocates have generally struggled to make inroads in the conservative legislature over recent years. That said, the state’s GOP governor said recently that Trump’s move to federally reschedule marijuana could add “a little bit of fire” to the local push for cannabis legalization in his state. Gov. Mike Braun (R) also said last year that he’s “amenable” to medical cannabis legalization. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Braun previously said that “it’s probably time” to allow access to therapeutic cannabis among patients in the state. Those comments came alongside a separate poll indicating that nearly 9 in 10 Indiana adults (87 percent) support marijuana legalization. Top Republicans in the legislature, however, have openly opposed marijuana reform. “It’s no secret that I am not for this,” Senate President Pro Tem Rodric Bray (R) said in late 2024. “I don’t have people coming to me with really compelling medical cases as to why it’s so beneficial. And any state that I’ve seen pass medical marijuana is essentially passing recreational marijuana.” House Speaker Todd Huston (R) doubted any medical benefits associated with marijuana, calling the substance “a deterrent to mental health.” He and others suggested that lawmakers supportive of the reform merely want to boost state revenue. A number of marijuana reform bills were introduced for the Indiana legislature’s 2025 session, including one—from Reps. Jim Lucas (R) and Shane Lindauer (R)—that would have legalized medical marijuana for people with “serious medical conditions as determined by their physician.” The post Indiana House Rejects Amendment To Let Farmers Begin Cultivating Marijuana Seeds appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Marijuana and other drugs are not as dangerous as laws written half a century ago say they are, according to a new scientific review. Since the passage of the Controlled Substances Act (CSA) in 1970, U.S. drug laws have been dictated by rigid categories that supposedly reflect the dangers posed by different substances—but the new study suggests that “drug policy contradicts expert assessments of drug harms” both in America and across the world. The results indicate that governments’ legal rankings for substances bear little resemblance to what experts actually know about which drugs cause the most harm—something that cannabis consumers and much of the general public have long recognized. Marijuana, for example, has been listed as a Schedule I drug in the U.S. for decades. While President Donald Trump signed an executive order directing the attorney general to expeditiously complete the process of moving cannabis to a Schedule III substance last month, that has not yet occurred. In the new paper published in the December 2025 issue of Harm Reduction Journal, a multidisciplinary panel of U.S. researchers, clinicians and people with lived experience of substance use found that federal drug policy is “poorly aligned with scientific evidence” and often contradicts expert assessments of risk. To reach their conclusions, the researchers adapted a method known as multi-criteria decision analysis. Seventeen experts evaluated 19 commonly used drugs across 18 categories of harm, ranging from overdose death and long-term health damage to family disruption, crime and economic cost. Each drug was scored and weighted to produce an overall harm ranking. The study—titled “US drug policy does not align with experts’ rankings of drug harms: a multi-criteria decision analysis”—also found that nearly all drugs were more harmful to the people who use them than to others, a result with significant policy implications. “An array of harm reduction strategies should be considered,” the authors argue, noting that punitive approaches have coincided with rising overdose deaths rather than declines in use. The findings arrive at a moment when federal and state officials are reconsidering long-standing approaches to drug regulation, sentencing and public health response. “For example, cannabis was rated as less harmful than its Schedule I status suggests.” By placing cannabis in the most restrictive legal category—while ranking fentanyl lower in Schedule II and leaving alcohol outside the federal drug scheduling system entirely—U.S. policy has created a framework that the authors say no longer reflects either scientific consensus or actual risk to the population. “Resources should be focused on health and wellness, not on incarceration,” they wrote. Taken together, the study paints a picture of a drug policy frozen in time—one that treats substances like cannabis and psilocybin as major threats while failing to adequately respond to the substances doing the greatest damage. As fentanyl deaths climb and alcohol-related harms persist, the authors suggest that aligning law with evidence is no longer just an academic concern, but a public health imperative. “Psilocybin and cannabis are associated with less harm than many other drugs and with potential medicinal benefits but people who use them remain subject to punishment in many jurisdictions.” The researchers argue that evidence-based scheduling could support a shift away from punitive enforcement and toward targeted harm reduction, expanded treatment access and public health interventions, particularly for fentanyl and alcohol. Noting that “fentanyl was deemed the most harmful drug,” they point to evidence supporting naloxone distribution, fentanyl test strips and supervised consumption sites. Calling for further examination, the authors write that the research “provides a useful starting point for future work in the U.S. that could account for additional drugs, drug benefits, vulnerable subpopulations (e.g., youth), and various methods of use and routes of ingestion.” “Collectively, this work can be used to advance scientific debate about the best ways to reduce harms to people who use drugs and to redress societal impacts at the same time.” The study comes on the heels of the Trump administration backing away from a prior federal recommendation to limit alcohol consumption to specific amounts, even as marijuana remains federally criminalized and more Americans are choosing cannabis for personal health reasons. More changes are also on the horizon. President Trump signed a bill into law last year containing provisions that would remove barriers to conducting research into the risks and benefits of marijuana, psychedelics and other Schedule I drugs. The post Marijuana’s Restrictive Federal Classification Isn’t Supported By Science, New Study Concludes appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Combinés : cumulez plusieurs sélections pour booster vos gains code promo 1xbet casino

You can be permitted to content artists, however it is not connections, in the event they are simply endorsed and additionally relating to question. iptv deutschland

Les autres offres accessibles avec le code promo 1xBet code promo 1xbet yaoundé

The "Wortendo word game" serves as a bridge between traditional word puzzles and modern digital interfaces, preserving the intellectual satisfaction of paper-based puzzles while adding the convenience and features of digital platforms. This hybrid approach respects the history of word games while leveraging technology's advantages, like instant dictionary validation and progress tracking.

The U.S. Department of Agriculture (USDA) is promoting a novel study suggesting that an often underutilized part of the hemp plant—its roots—may hold significant therapeutic potential, including in the treatment of pediatric cancer. Government scientists at USDA’s Agricultural Research Service (ARS) “redefined the value of roots in industrial hemp, providing new opportunities for industrial hemp growers and opening new avenues for pediatric cancer research,” the agency said in a press release this week. The study, published in the Journal of Cannabis Research last year, discovered that there’s a component of hemp roots with four distinct compounds known as “neolignans” that scientists until now have not realized exist in the cannabis crop. “We believe this new discovery offers industrial hemp growers a potential new revenue stream from a part of the plant that was previously overlooked,” Korey Brownstein, a research chemist at the National Center for Agricultural Utilization Research, said. “Unlike crops such as corn or soybeans, which have multiple uses, hemp has been limited in scope,” they said. “But if we treat hemp as a multi-use crop, we can expand its applications and market—paper, grain, fiber, and now, potentially, pharmaceutical compounds from the roots. The discovery of these compounds adds value to this commodity.” While it’s well-known that hemp contains valuable properties as it relates to fibers and grains, as well as extracts like CBD, the roots of the crop “were not considered to hold significant value,” USDA said. After identifying the unique chemical compound in the roots, however, researchers carried out a three-year study to determine whether there could be previously untapped utility in hemp. And working alongside scientists at the University of Illinois College of Medicine, they found the neolignans could have potential for pediatric cancer treatment. Learn more about a groundbreaking study in which ARS scientists are redefining the value of roots in industrial hemp. Their research could provide new opportunities for industrial hemp growers and also open new avenues for pediatric cancer research. https://t.co/kQSlo5NsfU pic.twitter.com/ovbM3E5tzZ — Agricultural Research Service (@USDA_ARS) January 14, 2026 Specifically, the researchers “found that these molecules showed moderate activity in killing pediatric cancer cells (cytotoxic effect) in the laboratory setting.” “Refining and understanding the effect of this molecule on pediatric cancers will open new alternatives for children’s cancers that are unresponsive to current therapies,” USDA said, adding that this “marks the first time these specific neolignans have been isolated from hemp and linked to possessing cytotoxic effects on pediatric cancer cell lines.” Further studies need to be conducted to validate the therapeutic efficacy of the hemp root compound, but Brownstein stressed that this could expand “the possibilities for using the whole industrial hemp plant.” “By adding value to the roots, we’re giving farmers more stability and more reasons to invest in this emerging crop,” he said. The study found that, of the four novel compounds that were tested, one in particular (M4) caused significant inhibition of cell survival in all four cancer cell lines in comparison to the control.” “While our findings demonstrate the cytotoxic effects of hemp-derived compounds on multiple pediatric cancer cell lines, the underlying mechanisms driving these effects remain to be elucidated,” the researchers wrote. “Future studies will focus on detailed mechanistic investigations including cell cycle analysis, apoptosis and necrosis assays, and pathway-level interrogations to uncover the molecular basis of this cytotoxicity.” “Though industrial hemp is more well-known for its cannabinoid content, it contains hundreds of other phytochemicals that may have uses in the functional food and pharmaceutical industry,” the study concluded. “Furthermore, utilizing each part of the hemp plant, including the roots, will reduce agricultural waste and provide additional value to growers.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, another scientific review recently found that CBD “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties. The study follows a series of encouraging discoveries related to the medical properties of cannabidiol. In 2025, for example, a paper published in the journal Pharmacology & Therapeutics, assessed a range of clinical and preclinical findings that the efficacy of chemotherapy drugs can be enhanced by medical marijuana. Also last year, a study found that “patients with cancer using cannabis report significant improvements in cancer-related symptoms.” Photo courtesy of Max Jackson. The post USDA Study Shows Untapped Potential Of Hemp Roots In Pediatric Cancer Treatment appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Break through mental blocks with our "letter boxed hints that actually help". We craft clues that target the puzzle's structural core, such as suggesting which letter cannot be an ending or hinting at a hidden thematic link between words.

Le code promo 1xBet 2026 : 1X200NEW vous permet de bénéficier d'un bonus de bienvenue de 100% jusqu'à 130 €/$ sur les paris sportifs. Une inscription 1xBet ne peut pas être réalisée depuis n’importe quel pays. En effet, le meilleur bookmaker en Afrique n’est disponible que dans certains pays. Voici donc les principaux d’entre eux. comment créer son code promo 1xbet

I found your this post while searching for some related information on blog search...Its a good post..keep posting and update the information. apollo group tv

I think this is an informative post and it is very useful and knowledgeable. therefore, I would like to thank you for the efforts you have made in writing this article. apollo group tv

Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. earn free robux Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. imei checking Excellent list — the server comparison tools simplified my decision. Side-by-side stats like drop rates and population were priceless. Real votes added the final confirmation. 메이저사이트 순위 I love how these outfits combine style and precision tailoring. Personalized latex designs make every piece feel special. The high-gloss finish looks incredibly sleek. Fast global delivery is a big advantage. togel 4d

Medical marijuana protections head to Trump’s desk; SC medical cannabis push boosted by federal rescheduling; NJ homegrow bills Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. Aidan Coffey: “Marijuana moment has always been my go to source for breaking news in the industry. I highly recommend the bill tracker to any industry professional.” If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Senate voted to send President Donald Trump a bill to continue protecting state medical cannabis laws from federal interference and without a separate rider that would have blocked the administration from rescheduling marijuana. Sens. Amy Klobuchar (D-MN), Rand Paul (R-KY) and Jeff Merkley (D-OR) filed a bill to delay the enactment of a law federally recriminalizing hemp THC products for another two years while lawmakers consider regulatory alternatives to prohibition. A South Carolina Republican senator said federal marijuana rescheduling as directed by President Donald Trump could boost efforts to legalize medical cannabis at the state level. New Jersey lawmakers filed bills to legalize home cultivation of marijuana by recreational consumers and medical cannabis patients. The Indiana Senate Commerce and Technology Committee approved a bill to restrict and regulate hemp THC products. The Missouri House Crime and Public Safety Committee held a hearing on legislation to align state hemp policy with recently approved federal restrictions. The Michigan House Rules Committee held a hearing on a bill to establish a statewide cannabis reference laboratory to standardize and audit other testing facilities. The Montana Department of Revenue reported that retailers have sold more than $1 billion worth of recreational marijuana products since legalization took effect in 2022. / FEDERAL The Drug Enforcement Administration filed a rule defining “cannabimimetic agents,” identifying 18 additional substances that meet the definition and consolidating existing administration controlled substances code numbers into a number for substances meeting the definition. A spokesperson for Sen. James Lankford (R-OK) said he’s “concerned that youth use has increased since medical marijuana was legalized in Oklahoma, and that reclassification sends the wrong message before the health impacts are fully understood.” Rep. Eleanor Holmes Norton (D-DC) sent a press release expressing disappointment that the House passed a funding bill containing a provision to continue blocking Washington, D.C. from legalizing recreational marijuana sales. Former Sen. Kyrsten Sinema (I-AZ) is being sued by the ex-wife of a former bodyguard who she has credited with inspiring her work on psychedelics reform. The House bill to delay the enactment of the federal recriminalization of hemp THC products got two new cosponsors for a total of 17. / STATES Colorado Gov. Jared Polis (D) said in his State of the State address that he’s been “called many things—Colorado’s education governor, marijuana governor, tech bro governor, gay governor, socialist, fascist, communist, capitalist, libertarian.” Tennessee’s lieutenant governor said he doesn’t support legalizing medical cannabis. The Center for Rural Pennsylvania held a hearing on hemp issues. Massachusetts House and Senate lawmakers expressed optimism about ongoing negotiations to reconcile legislation to restructure the Cannabis Control Commission. New Jersey’s Senate president introduced legislation to criminalize purchasing marijuana from a seller that is not a licensed dispensary. Delaware lawmakers filed a bill to allow terminally ill patients to use medical cannabis in health care facilities. An Oklahoma representative introduced a bill to protect medical cannabis patients from DUI charges when they are not actually impaired. The Florida Office of Election Crimes and Security is auditing petitions for a proposed marijuana legalization ballot initiative. California regulators announced a recall of marijuana products due to packaging and labeling that is attractive to children. Minnesota regulators published required reports to the legislature about various cannabis issues. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The Virginia Beach, Virginia City Council received recommendations from a cannabis task force about preparing for potential statewide legalization of recreational marijuana sales. / INTERNATIONAL Venezuelan Acting President Delcy Rodríguez has been labeled as a “priority target” by the U.S. Drug Enforcement Administration. A Jersey lawmaker discussed the benefits of pending cannabis decriminalization legislation. / SCIENCE & HEALTH A study provided “compelling evidence for the therapeutic potential of CBD oil in mitigating motor and cognitive deficits and neuropathological changes associated with” Alzheimer’s disease. A study found that “about 10 % of Germans report to having cultivated cannabis at home.” A study found that cannabis strains with THC and CBD “exhibit significant anticancer activity against [urothelial carcinoma] cell lines and ex vivo models.” / ADVOCACY, OPINION & ANALYSIS A poll of Florida voters funded by the state Chamber of Commerce found that 51 percent support legalizing marijuana. The Coalition for Cannabis Policy, Education, and Regulation changed its name to the Coalition for Cannabinoid Policy, Education, and Regulation. / BUSINESS Verano Holdings Corp. announced that its revolving credit facility commitment was increased from $75 million to $100 million and that the maturity date was extended from September 29, 2028 to February 28, 2029. / CULTURE Matt Damon and Ben Affleck spoke about ibogaine and other psychedelics with Joe Rogan. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Senators push to delay federal hemp THC ban (Newsletter: January 19, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I love the vibe of the "Back to the 90's" event! It really takes me back to a simpler time filled with good music and great friends. Speaking of slopes, just like a fun ride down a hill, events like these create a positive slope in our lives, elevating our spirits and bringing us together. It's all about the upward momentum of community and connection!

Your dedication to connecting people and advocating for the community is truly inspiring. Just like in a game of bat smash game, where teamwork and strategy lead to success, your efforts in political consulting and your campaign for the Centennial School Board show that collaboration can create positive change.

1xBet est une plateforme de paris sportifs et de casino en ligne fondée en 2007. Elle opère sous une licence internationale délivrée par les autorités de Curaçao (numéro 1668/JAZ ou équivalent, selon les sources récentes en 2025). Cette licence, émise par le Curaçao eGaming ou le Gaming Control Board de Curaçao, est l'une des plus courantes dans l'industrie des jeux en ligne. Elle autorise 1xBet à proposer ses services dans de nombreux pays à travers le monde, y compris une grande partie de l'Afrique francophone. code promo 1xbet gratuit 2026

Good post but I was wondering if you could write a litte more on this subject? I’d be very thankful if you could elaborate a little bit further. Appreciate it! slot online

Beyond the official levels, geometry online truly thrives because of its user-generated content. The built-in level editor allows players to design their own stages using a vast array of tools, triggers, and decorative elements.